Bristlecone Advisors, LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History
Bristlecone Advisors, LLC
- $1.21 Billion
- Q1 2025
A detailed history of Bristlecone Advisors, LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Bristlecone Advisors, LLC holds 23,900 shares of XBI stock, worth $2.02 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
23,900
Previous 19,048
25.47%
Holding current value
$2.02 Million
Previous $1.72 Million
13.0%
% of portfolio
0.16%
Previous 0.14%
Shares
9 transactions
Others Institutions Holding XBI
# of Institutions
846Shares Held
108MCall Options Held
17.7MPut Options Held
28.5M-
Goldman Sachs Group Inc New York, NY13.1MShares$1.11 Billion0.18% of portfolio
-
Morgan Stanley New York, NY10.9MShares$924 Million0.07% of portfolio
-
Citigroup Inc10.5MShares$887 Million0.45% of portfolio
-
Jpmorgan Chase & CO New York, NY10.4MShares$878 Million0.07% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A68.49MShares$719 Million1.54% of portfolio